Neurologic complications of immune checkpoint inhibitors.
Haugh AM, Probasco JC, Johnson DB.
Expert Opin Drug Saf. 2020 Apr;19(4):479-488. doi: 10.1080/14740338.2020.1738382. Epub 2020 Mar 11.
Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma.
San-Miguel J, Dhakal B, Yong K, Spencer A, Anguille S, Mateos MV, Fernández de Larrea C, Martínez-López J, Moreau P, Touzeau C, Leleu X, Avivi I, Cavo M, Ishida T, Kim SJ, Roeloffzen W, van de Donk NWCJ, Dytfeld D, Sidana S, Costa LJ, Oriol A, Popat R, Khan AM, Cohen YC, Ho PJ, Griffin J, Lendvai N, Lonardi C, Slaughter A, Schecter JM, Jackson CC, Connors K, Li K, Zudaire E, Chen D, Gilbert J, Yeh TM, Nagle S, Florendo E, Pacaud L, Patel N, Harrison SJ, Einsele H.
N Engl J Med. 2023 Jul 27;389(4):335-347. doi: 10.1056/NEJMoa2303379. Epub 2023 Jun 5.
Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group.
Puzanov I, Diab A, Abdallah K, Bingham CO 3rd, Brogdon C, Dadu R, Hamad L, Kim S, Lacouture ME, LeBoeuf NR, Lenihan D, Onofrei C, Shannon V, Sharma R, Silk AW, Skondra D, Suarez-Almazor ME, Wang Y, Wiley K, Kaufman HL, Ernstoff MS; Society for Immunotherapy of Cancer Toxicity Management Working Group.
J Immunother Cancer. 2017 Nov 21;5(1):95. doi: 10.1186/s40425-017-0300-z.
CAR-HEMATOTOX: a model for CAR T-cell-related hematologic toxicity in relapsed/refractory large B-cell lymphoma.
Rejeski K, Perez A, Sesques P, Hoster E, Berger C, Jentzsch L, Mougiakakos D, Frölich L, Ackermann J, Bücklein V, Blumenberg V, Schmidt C, Jallades L, Fehse B, Faul C, Karschnia P, Weigert O, Dreyling M, Locke FL, von Bergwelt-Baildon M, Mackensen A, Bethge W, Ayuk F, Bachy E, Salles G, Jain MD, Subklewe M.
Blood. 2021 Dec 16;138(24):2499-2513. doi: 10.1182/blood.2020010543.
Mammalian meat allergy.
Wong XL, Sebaratnam DF.
Int J Dermatol. 2018 Dec;57(12):1433-1436. doi: 10.1111/ijd.14208. Epub 2018 Sep 4.
Neurotoxicity and Immunotherapy.
Kopecký J.
Klin Onkol. 2020 Winter;33(1):11-14. doi: 10.14735/amko202011.
[Food intolerance].
Zugasti Murillo A.
Endocrinol Nutr. 2009 May;56(5):241-50. doi: 10.1016/S1575-0922(09)71407-X. Epub 2009 Jul 1.
Rheumatologic Diseases and the Liver.
Gebreselassie A, Aduli F, Howell CD.
Clin Liver Dis. 2019 May;23(2):247-261. doi: 10.1016/j.cld.2018.12.007. Epub 2019 Mar 8.
Pembrolizumab-Induced Liver Injury: Beyond Immune-Mediated Hepatitis.
Herms Q, Fuster-Anglada C, Juanola A.
Gastroenterology. 2024 Aug;167(3):443-445. doi: 10.1053/j.gastro.2024.01.046. Epub 2024 Feb 5.
Toxicities associated with checkpoint inhibitors-an overview.
Spiers L, Coupe N, Payne M.
Rheumatology (Oxford). 2019 Dec 1;58(Suppl 7):vii7-vii16. doi: 10.1093/rheumatology/kez418.
